Intellectual property, drug licensing, freedom of information, and public health

被引:20
作者
Roberts, I
Po, ALW
Chalmers, L
机构
[1] Inst Child Hlth, Dept Epidemiol & Publ Hlth, Child Hlth Monitoring Unit, London WC1N 1EH, England
[2] Univ Nottingham, Sch Pharm, Ctr Evidence Based Pharmacotherapy, Nottingham NG7 2RD, England
[3] UK Cohrane Ctr, NHS R&D Programme, Oxford, England
关键词
D O I
10.1016/S0140-6736(98)07600-4
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:726 / 729
页数:4
相关论文
共 18 条
[1]
[Anonymous], 1998, ABPI COMP DAT SHEETS
[2]
*BIO PROD LAB, ALB CLIN PAP
[3]
Meeting the challenges facing research ethics committees: some practical suggestions [J].
Blunt, J ;
Savulescu, J ;
Watson, AJM .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7124) :58-61
[4]
BOSELEY S, 1998, GUARDIAN 0218, P2
[5]
EFFECT OF ALBUMIN SUPPLEMENTATION DURING PARENTERAL-NUTRITION ON HOSPITAL MORBIDITY [J].
BROWN, RO ;
BRADLEY, JE ;
BEKEMEYER, WB ;
LUTHER, RW .
CRITICAL CARE MEDICINE, 1988, 16 (12) :1177-1182
[6]
*CEM CMO, 1998, CEMCMO9811
[7]
*COCHR INJ GROUP A, 1998, COCHR LIB
[8]
Too soon to market [J].
Dent, THS ;
Hawke, S .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7118) :1248-1249
[9]
[10]
ETHICAL IMPERATIVE TO PUBLISH EXTENDS TO ACADEMICS TOO [J].
HORROBIN, DF .
BRITISH MEDICAL JOURNAL, 1995, 311 (7006) :688-688